Cellular Therapy

Cellular therapy is explicitly non-covered by this policy and is not considered reasonable and necessary under section 1862(a)(1). The policy cites lack of scientific/statistical evidence of efficacy and potential danger from practices such as injecting foreign proteins (e.g., placenta or fetal lamb lung tissue) as the basis for denial.

"Cellular therapy (including injection of foreign proteins such as placenta or fetal lamb lung tissue) is not considered reasonable and necessary under section 1862(a)(1) and is therefore non-covered."

Sign up to see full coverage criteria, indications, and limitations.